ArticleCurrent oncology (Toronto, Ont.)2025

Single-Center Real World Study of Everolimus and Exemestane in HR+/HER2- Metastatic Breast Cancer Following CDK4/6 Inhibitor Therapy.

Yunus Emre Altıntaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.